Moderna Shares Drop After Cancer Vaccine Leak
Moderna and Merck share new cancer vaccine data after an early leak shakes the stock.
Moderna stock took a surprise hit today. Numbers for its major cancer shot leaked online early. Investors rushed to sell before the company could explain the full story.
Moderna works with Merck on this treatment. The two drugmakers released the complete trial results right after the drop. The shot shows strong results against skin cancer. It helps patients live longer without the disease returning.
Wall Street traders often react to speed over substance. They saw early leaks and hit the sell button. Yet the medicine works well in testing. The partnership remains on track to bring the shot to the public.
Everyday investors should look past the quick price swings. Drug development takes time. Strong medicine matters more than morning market panic.
Source: CNBC
More from Biotech
